Lupin Q1 Results
- BSE: 500257
- NSE: LUPIN
- ISIN: INE326A01037
- Sector: Biotechnology & Drugs
BSE
1,953.55
28.80 (1.50%)
28.80 (1.50%)Volume17.71 K
Updated: Tue 15 Jul, 2025 | 15:29:35
NSE
1,950.7024.60 (1.28%)
24.60 (1.28%)Volume9.90 L
Updated: Tue 15 Jul, 2025 | 15:53:09
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q1 Results Highlights
Note: Comparison is on QoQ basis
Quarterly - Lupin Q1 Results
*All figures in crores except per share values
| Fiscal Period | Jun 24 | Mar 25 | QoQ Comp |
|---|---|---|---|
| Total Operating Expense | 4,561.68 | 4,768.19 | 3.29% |
| Depreciation/ Amortization | 247.71 | 393.18 | -45.81% |
| Operating Income | 1,038.65 | 898.94 | 90.83% |
| Net Income | 801.31 | 772.52 | 122.94% |
| Other Operating Expenses Total | 1,598.37 | 1,687.56 | 7.28% |
| Net Income Before Taxes | 993.03 | 895.84 | 99.52% |
| Total Revenue | 5,600.33 | 5,667.13 | 12.89% |
| Selling/ General/ Admin Expenses Total | 971.04 | 1,001.25 | 7.87% |
| Diluted Normalized EPS | 17.52 | 16.87 | 123.06% |